<PAGE> 1
Exhibit 23.1
We consent to the incorporation by reference in the Registration Statements
(Form S-8 Nos. 333-32400, 333-89495, 333-89497, 333-67089 and 333-45375) and the
Registration Statement (Form S-3/A, No. 333-84841) of Corixa Corporation of our
report dated January 27, 2000, with respect to the consolidated financial
statements of Coulter Pharmaceutical, Inc. for the year ended December 31, 1999
included in Corixa Corporation's Current Report on Form 8-K dated December 22,
2000, filed with the Securities and Exchange Commission.
Ernst & Young LLP
Palo Alto, California
December 28, 2000
